Compare Vaxcyte Inc. Common Stock (PCVX) vs Vicor Corporation Common Stock (VICR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Vicor Corporation Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B), while Vicor Corporation Common Stock trades at $234.03 (market cap $12.30B). The key difference: Vicor Corporation Common Stock is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Vicor Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Vicor Corporation Common Stock for 0 Days on average.
| PCVX | VICR | |
|---|---|---|
Market Cap | $10.51B | $12.30B |
Volume | 2,644,694 | 1,052,269 |
Sector | Health | Technology |
52-Week High | $73.82 | $379.78 |
52-Week Low | $40.32 | $57.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $11.86B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Vicor Corporation Common Stock
Vicor Corporation designs, manufactures, and markets modular power components and complete power systems, serving high-performance computing, data center, industrial, automotive, and aerospace and defense markets.
Read more on VICR →
